| Names | |
|---|---|
| Preferred IUPAC name | 2-hydroxy-6-(trifluoromethyl)pyridine |
| Other names | 2-Hydroxy-6-(trifluoromethyl)pyridine 6-(Trifluoromethyl)-2-pyridinol 6-(Trifluoromethyl)-2-hydroxypyridine 6-Trifluoromethyl-2-pyridinol 2-Hydroxy-6-trifluoromethylpyridine |
| Pronunciation | /tuː-haɪˈdrɒk.si-sɪks-traɪˌfluːəˈrɒ.mɪl.pɪˈrɪd.iːn/ |
| Identifiers | |
| CAS Number | 183612-67-7 |
| Beilstein Reference | 2622032 |
| ChEBI | CHEBI:18950 |
| ChEMBL | CHEMBL420995 |
| ChemSpider | 26715 |
| DrugBank | DB07974 |
| ECHA InfoCard | 13-2-0738665654-44-0000 |
| Gmelin Reference | 7892.13 |
| KEGG | C14130 |
| MeSH | D016728 |
| PubChem CID | 141621 |
| RTECS number | UW6825000 |
| UNII | 9W45P32K9D |
| UN number | UN3334 |
| Properties | |
| Chemical formula | C6H4F3NO |
| Molar mass | 161.10 g/mol |
| Appearance | Colorless liquid |
| Odor | sweet odor |
| Density | 1.39 g/cm3 |
| Solubility in water | Slightly soluble |
| log P | 1.2 |
| Vapor pressure | 0.5 mmHg (25°C) |
| Acidity (pKa) | 5.5 |
| Basicity (pKb) | 5.19 |
| Magnetic susceptibility (χ) | -47.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.444 |
| Viscosity | 1.283 cP (20°C) |
| Dipole moment | 2.2095 Debye |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 165.7 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -544.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -994.7 kJ·mol⁻¹ |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 + H315 + H319 + H335 |
| Precautionary statements | P261, P264, P271, P272, P273, P280, P302+P352, P305+P351+P338, P337+P313, P362+P364 |
| NFPA 704 (fire diamond) | 1-1-0-☢ |
| Flash point | Flash point: 113°C |
| Autoignition temperature | 430°C |
| Lethal dose or concentration | LD50 oral rat > 2000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral, rat: 1795 mg/kg |
| NIOSH | Not established |
| PEL (Permissible) | Not established |
| REL (Recommended) | NIOSH REL: Not established |
| IDLH (Immediate danger) | No IDLH established |
| Related compounds | |
| Related compounds | 2-Hydroxypyridine 6-Trifluoromethylpyridine 2-Chloro-6-trifluoromethylpyridine 2-Amino-6-trifluoromethylpyridine 2-Methoxy-6-trifluoromethylpyridine 2-Hydroxy-3-trifluoromethylpyridine 4-Hydroxy-6-trifluoromethylpyridine |
| Parameter | Detail | Manufacturer Commentary |
|---|---|---|
| Product Name & IUPAC Name | 2-Hydroxy-6-trifluoromethylpyridine IUPAC: 2-hydroxy-6-(trifluoromethyl)pyridine |
Nomenclature in our technical records aligns with the IUPAC convention for unambiguous identification. This reduces nomenclature confusion in custom synthesis contracts and helps avoid accidental mislabeling during multi-step processes. Naming accuracy is crucial at goods receipt and during in-process sample identification, mainly where downstream plant environments handle multiple substituted pyridines. |
| Chemical Formula | C6H4F3NO | Formula reflects the fully fluorinated methyl group on the pyridine skeleton. Variability in elemental composition rarely occurs unless starting material identity or substitution patterns drift outside specifications, which must be checked by both in-house QC and third-party analytical verification, especially before bulk campaigns. |
| Synonyms & Trade Names | 6-(Trifluoromethyl)-2-pyridinol 2-Hydroxy-6-(trifluoromethyl)pyridine |
Technical documents distinguish structural synonyms to minimize batch allocation errors. Some customers specify synonyms based on patent filings or historic purchasing. Our intake screen checks synonym consistency three times—from procurement request, through batch labeling, to shipping documents—to maintain regulatory traceability. |
| HS Code & Customs Classification |
HS Code: 293339 Customs Classification: Heterocyclic compounds with nitrogen hetero-atom(s) only |
6-(Trifluoromethyl)-2-pyridinol falls under global HS code 293339. Border crossing requires each drum/IBC to reference this code, and region-specific tariffs or restrictions may trigger additional scrutiny for products with trifluoromethyl substituents, due to their origin or downstream end-uses. Customs brokers confirm classification consistency per shipment, though customer declarations affect the documentary stack. Our compliance lead reviews every country-specific code update since some markets amend the HS subheading based on fluorine content or aromatic substitution. |
Industrial batches of 2-Hydroxy-6-trifluoromethylpyridine usually appear as off-white to light yellow crystalline solids. The material can present as a powder or compacted lumps, depending on downstream drying and finishing technique. Odor is typically faint and characteristic of substituted pyridines, relevant for ventilation planning in bulk handling.
Melting point and boiling point values fluctuate with process route and residual solvent content, requiring batch-specific verification for formulation-critical applications. Density figures also show grade dependence, especially between technical and high-purity grades. Packed bulk product often exhibits variable flowability, requiring vibration or nitrogen purging for large-scale transfer.
Process engineers note that 2-Hydroxy-6-trifluoromethylpyridine maintains chemical integrity under ambient storage when protected from excess moisture and light. Exposed storage in humid environments increases risk of hydrolysis or discoloration, which can carry through to formulated products. Downstream users should consider potential for side reactions with strong acids or oxidants.
Solubility in organic solvents, especially polar aprotic types, is generally high. Aqueous solubility depends on pH and formulation requirements; elevated pH increases dissolution rate. Experience shows significant lot-to-lot variation when residual process salts remain. Solution prep for high-purity use calls for pre-filtration to remove trace solids introduced during handling.
Grades include technical, intermediate, and electronic or pharmaceutical grades. Purity thresholds vary by specification and customer-driven target. Water content, color index, and residual solvents represent key points of differentiation.
Observed impurities mainly arise from unconverted starting materials, partially hydrolyzed byproducts, and downstream process residues. Acceptable limits are not universal; they depend on customer application (e.g. agrochemical synthesis vs. active ingredient).
Quality control relies on a mix of HPLC, GC, and NMR to monitor purity and impurity classes. Some clients specify additional elemental analysis or Karl Fischer titration for water. The final release standard is subject to internal QC criteria and client-negotiated limits. Batch records record all deviations from established control parameters.
Key precursors include trifluoromethylpyridine derivatives and hydroxylating agents. Source selection weighs in favor of suppliers with consistent isomer purity and minimal trace halide content. Process reliability depends on batch traceability and incoming quality review.
The main approach involves selective hydroxylation or substitution on the pyridine ring under controlled conditions. Reaction setup, catalyst selection, and temperature control directly affect yield and impurity generation. Continuous assessment of isomer formation ensures process robustness for higher grades.
Critical control points include pH regulation, quench conditions, and solvent exchange procedures. Crude product must undergo filtration and solvent washes to remove residual process reagents. Higher grade requirements often trigger extra distillation or recrystallization cycles. ERP-integrated tracking of process steps reduces batch variation and facilitates root-cause analysis if issues develop.
Batch release depends on full-spectrum review of purity, impurity profile, water content, and visual inspection. Repeat testing across process stages helps pinpoint drift in analytical signals or unexpected contamination. Release trigger points tie directly to the contracted application or regulatory filing, not a generic industry-wide standard.
2-Hydroxy-6-trifluoromethylpyridine typically undergoes etherification, acylation, or halogenation in downstream synthesis. Nucleophilic substitution at the hydroxyl site depends strongly on steric hindrance and base selection.
Industrial modifications require careful control of temperature and solvent polarity. Widely adopted catalysts include phase-transfer agents or non-nucleophilic bases. Excess heating can initiate side-reactions or discoloration, stressing the need for real-time temperature and pH monitoring set by process-specific recipes.
The compound serves as a key intermediate for agrochemical active ingredients, specialty pharmaceutical scaffolds, and electronic material additives. Downstream purity demands dictate the extent of pre-use purification and possible secondary functionalization protocols.
Industrial storage rests on dry, temperature-moderated conditions protected from direct sunlight and strong oxidizers. Humidity incurs progressive hydrolysis or caking, complicating further handling. Some users opt for nitrogen or argon blanket for pharma-grade lots.
Standard practice favors HDPE drums or lined steel containers, confirmed inert to both product and ambient atmosphere. Solvent residue or reuse of non-approved packaging increases risk of off-spec contamination. All incoming and outgoing drums are inspected visually and by spot sampling for degradation or breach.
Manufacturers track shelf life lot-wise, since exposure history (humidity, seal integrity) and grade-specific impurity profiles drive stability. Visual yellowing, lump formation, or acid odor signal advancing degradation. Shelf life review links with the user’s application specification and downstream revalidation is recommended for lots at expiry.
2-Hydroxy-6-trifluoromethylpyridine GHS hazard status depends on both national and regional regulations as well as batch purity. Bulk handling documentation provides precautionary and hazard statements based on incoming batch certificate and region of use.
Potential risks include skin and eye irritancy, with higher grades or dust-prone batches requiring local exhaust and PPE. Spill and exposure response protocols derive directly from observed acute toxicity and as-advised regulator data for the specified grade.
Available toxicity information primarily reflects animal studies and workplace exposure incidents. Data suggests a need for measured handling to avoid accidental contact or ingestion. Engineering controls such as ventilation and automated transfer take precedence in bulk packaging operations.
Monitored exposure limits are defined on a per-site and per-region basis, grounded in occupational health studies and product application. Internal handling SOPs include exhaustive PPE requirements, spill containment protocols, and decontamination steps, reviewed regularly based on incident tracking.
Production volumes of 2-Hydroxy-6-trifluoromethylpyridine reflect the constraints and flexibility typical of fluorinated pyridine manufacturing. Output is directly linked to fluorinating reagent availability, regulatory controls on precursor chemicals, and scheduling of campaign-based synthesis. For pharmaceutical and electronic applications, we operate multi-purpose reactors with dedicated cleaning validation. Downstream purification—critical for high-purity grades—depends on current campaign loads. Supply commitments prioritize long-term contractual partners, with overflow adjusted based on quarterly forecasting trends and spot market feedback.
Standard lead times range from several weeks for stock items up to several months for made-to-order or custom-spec batches. Timeframes are dictated by both batch scheduling and analytical release cycles—especially where extended impurity profiling and third-party analytical validation are required. MOQ depends on grade and packaging preference. Lab and pilot grades may allow for deliveries below typical wholesale MOQs, but commercial grade orders align with reactor batch volumes or intermediate storage unit limits.
Packing formats are grade- and destination-specific. Bulk packaging uses HDPE or fluoropolymer-lined drums with nitrogen protection for high-purity or moisture-sensitive material. Small-scale research grades are packed under inert atmosphere where trace moisture or oxygen could shift impurity profiles. For markets with mandatory transportation or environmental certifications, packaging selection adapts to hazard labeling and local stewardship rules.
Shipping aligns with hazard classification and route-specific compliance procedures. For controlled or regulated destinations, pre-clearance documentation may delay shipment release. Payment terms commonly mirror the customer's procurement cycle, with progressive milestones in the case of custom synthesis or scale-up validation. Price locks or indexation clauses may be proposed during times of expected raw material volatility, subject to mutual agreement.
Raw material cost for 2-Hydroxy-6-trifluoromethylpyridine is shaped primarily by the market for trifluoromethylating agents (e.g., TMSCF3, CF3I), pyridine derivatives, and specialty catalysts. Surges in demand for semiconductor or agrochemical ingredients can cause price spikes in precursor chemicals. Regulatory changes, especially those relating to fluorinated compound handling and emissions, also affect supply chain costs. Grade-specific impurity requirements and additional purification steps—such as chromatography or fractional distillation for pharmaceutical grades—carry a substantial process premium.
Product pricing shifts with the required purity, impurity profile, and approval documentation. Pharmaceutical grades—requiring low residual metal content, validated impurity pathways, or ICH Q3D compliance—command the highest price points. Electronic material grades may demand ultra-trace impurity analysis or ion chromatography certification. Lower-purity or technical-grade product, intended for intermediates use in non-pharma applications, follows a different release standard and thus presents a price reduction reflecting less intensive QA/QC protocols. Packaging certifications, such as UN-approved containers for hazardous goods, add further cost differences due to compliance and material selection.
Global demand for 2-Hydroxy-6-trifluoromethylpyridine is concentrated in pharmaceutical intermediates, agrochemical synthesis, and specialty materials sectors. Tight integration with upstream fluorine chemistry makes the market price responsive to production outages or regulatory enforcement in key regions. In stable years, contractual steady offtake from multi-national pharma stabilizes volumes. Still, demand spikes for emerging drug or crop protection pipelines can stretch available supply, especially for high-purity and validated grades.
North America and the European Union focus on pharmaceutical-grade demand, especially for API intermediates. Regulatory scrutiny and REACH registration pressures drive preference for transparent quality documentation. Japan shows similar expectations, coupled with unique electronic material requirements. China supports both domestic and export demand, leveraging cost-competitive raw materials and bulk synthesis capabilities but also sees disruption from local environmental enforcement and licensing. India’s demand is driven by generic pharma and process development, with sourcing challenges whenever precursor supply constricts, prompting regular price negotiations.
Expectations for 2026 indicate relative price firmness for high-grade material due to rising regulatory and analytical compliance costs, and the ongoing migration to more sustainable process routes. Fluctuations in trifluoromethylating agent supply and energy inputs could affect technical-grade pricing. Broader adoption of end-to-end digital batch traceability may compress margins for commoditized grades, but premiumization via impurity control and documentation will keep specialty grades at higher price points.
Market observations draw on internal order book analysis, direct supply partner feedback, trade data review, and external sector reports where available. Price forecasting considers recent multi-year volatility in fluorinated raw materials, regulatory developments in major consuming regions, and surveyed end-user procurement intentions.
Production routes are under review due to evolving environmental standards around fluorinated byproduct management. Some regional producers have pivoted toward lower-impact process variants, seeking to align with upcoming emissions rules. Market entries of Asian capacity have shifted competitive dynamics, especially for technical and industrial grades.
New or revised regulations in the EU and California on PFAS and related fluorinated substances are raising documentation requirements for both raw materials and finished pyridine derivatives. Traceability for source materials and disclosure of process emissions affect product clearance timelines for export. REACH dossiers and US TSCA notifications have required expanded analytical evidence and supply chain transparency, increasing both cost and lead time for new registrations.
Process optimization emphasizes impurity minimization, energy efficiency, and reduction of direct fluorinated waste streams. Batch tracking systems and advanced in-process analytics reduce out-of-spec risks and help align final product with evolving client specifications. For customers anticipating regulatory-driven grade changes, advance technical consultations and collaborative validation trials mitigate supply chain disruptions and ensure timely qualification under revised standards.
2-Hydroxy-6-trifluoromethylpyridine serves as a functional intermediate in agrochemical synthesis, pharmaceutical building blocks, and as a precursor in specialty chemical manufacture. Industrial R&D teams leverage its structural motifs for development of active compounds targeting crop protection and therapeutic pipelines. Custom synthesis and process development units rely on this intermediate where electron-withdrawing effects or specialized ring substitution patterns are required. In pilot plants, purity shifts influence whether a batch can proceed into high-value API synthesis, formulation steps, or must divert into less-sensitive industrial products.
| Application | Usual Grade Required | Critical Quality Considerations |
|---|---|---|
| Pharmaceutical Synthesis | High Purity / Low Residue Grade | Trace metals, organic impurities, residual solvents—subject to customer and regulatory standards. |
| Agrochemical Intermediates | Technical Grade | Stable impurity profile, controlled isomer content, minimized halogenated side-products. |
| Specialty Chemical Synthesis | Custom or Standard Industrial Grade | Project-specific purity, solvent compatibility, batch-to-batch consistency. |
Production departments will clarify if the use case is in regulated final product streams (e.g., pharma synthesis), pre-API intermediates, pilot process scale-up, or technical bulk blending. This affects all subsequent control points and grade decisions.
Compliance reviews identify if the target country or customer guideline triggers need for GMP controls, ICH Q3A/B impurity thresholds, EPA pesticide ingredient tracking, or custom in-house quality agreements. Traceability and batch certification requirements often follow from this step.
Internal QC labs compare required impurity limits against historically achievable purity profiles for each grade. In pharma, single-digit ppm targets for key impurities could dictate additional chromatography or a change in the process route altogether. Agro and specialty applications focus more on rejecting batches with off-color or excess by-products.
For large-scale users or blending operations, technical grade usually aligns with economic expectations, trading off ultra-high purity for manufacturing cost savings. High value-add syntheses push the need for smaller, certified lots with full CoA and batch traceability—this can impact lead time and minimum order size.
Actual validation relies on in-house downstream testing or process simulation. Manufacturing and QC teams, using both internal data and customer feedback, can adjust purification steps or rework protocols based on real-world test results. Early engagement remains the most reliable way to avoid scale-up surprises and ensure fit-for-purpose supply.
Quality management frameworks serve as the backbone of daily operations. Consistent production hinges on documented procedural controls and continuous operator training. Site accreditation, such as ISO 9001, reflects this systemic approach, ensuring that each campaign—regardless of batch size or complexity—traces every critical raw material, line cleaning, and process step. Facility audits occur per schedule and on-demand for project launches or upon customer audit requests. Teams collaborate across QC, QA, and production to address and implement corrective actions after internal reviews or regulatory inspection findings.
Certification demands depend on downstream sector and region. Pharmaceutical and agrochemical intermediates often require registration-supporting documentation or declarations aligned with specific regulatory systems. For 2-Hydroxy-6-trifluoromethylpyridine, documentation aligns with typical requirements for intermediate and research use, unless a customer project triggers GMP or similar enhanced compliance. Veterinary and specialty applications sometimes require confirmation of absence of animal-derived processing aids, which we provide via supplier declarations and internal record checks. Batch documentation encompasses synthesis route, batch history, and results from compound-specific analytical testing.
Production releases reflect actual process performance: in-process check records, product release analytical data, and observed impurity profiles. Certificates of Analysis are batch-resolved, linking traceable batch numbers to test records. Upon customer request, we provide method summaries and chain of custody tracking back to core materials. Custom analytical development—such as method validation or stability-indicating testing—is carried out only per technical agreement, as this requires tailored resource allocation and timeline adjustment. Reach and GHS safety documentation, if required by region or customer project, are prepared according to in-force regulations and internal compliance workflows, with materials characterization focused on those impurity or trace element classes relevant to grade or intended use.
Prevailing output levels depend on campaign production, feedstock availability, and process yield. Demand forecasts drive procurement cycles for critical starting materials and, when necessary, engage alternate suppliers to buffer upstream risk. Onboarding new customers typically includes short-term allocation through pilot-scale lots, with scaling to commercial batch volume after technical alignment. Contract approaches include both fixed-volume scheduling and rolling-calloff, according to downstream consumption pattern and inventory policies at the client site.
Sustained output reflects both physical reactor line availability and experienced shift teams. Supply chain stability is maintained through dual-sourcing of sensitive feeds and the use of process-intensification steps to suppress byproduct formation. Capacity bottlenecks, such as isolation or purification stages, trigger in-house troubleshooting or expansion planning. Volatility in energy markets or logistics may prompt cost adjustments or delivery schedule updates, and communication with key accounts becomes more frequent during such cycles.
Sample requests follow a controlled release workflow, validated by technical fit and intended downstream testing scenarios. Discussions with customer technical staff clarify necessary grade, preferred lot size, and documentation requirements. QC characterizes the sample lot at dispatch, and documents cover the specific analytical criteria as requested. On return of evaluation feedback, additional material can be scheduled under the agreed ramp-up plan, with adjustment possible for special packaging or extra analytical data if pilot application warrants.
Business relationships scale from order-by-order evaluation to long-term, forecast-covered agreements. Industries requiring rapid response—R&D labs, launch projects—benefit from split or staged deliveries, which balance client flexibility against upstream scheduling constraints. Minimum order quantities, customer-specific packaging, and special logistics handling can be negotiated as part of framework agreements. Custom documentation support, deviation management, and technical troubleshooting are available, subject to clear scope definition and resource planning between account and technical teams.
R&D currently centers on process intensification, purification of isomeric byproducts, and novel catalytic systems for selective trifluoromethylation. Most technical groups probe for alternatives to traditional chlorofluorocarbon reagents, given environmental and regulatory pressures. Key focus rests on in-situ generation of CF3-sources and step-reduction strategies that minimize waste streams and improve atom economy.
The pharmaceutical sector pushes the demand for this compound as a core structure in heterocyclic scaffolds for agrochemical candidates and drug discovery pipelines. Developers specifically seek intermediates for fluorinated pyridine derivatives, given their role as enzyme inhibitors or building blocks for crop protection agents. Research teams in electronics chemicals monitor potential as a precursor in the synthesis of specialty ligands, advanced materials, and functional performance additives in display technologies.
Key challenges include controlling regioselectivity during ring functionalization and removing trace metal/halide impurities resulting from catalytic routes. Technical progress has come from in-line monitoring of reaction pathways using real-time NMR or LC-MS, helping trap intermediates before decomposition. Batch-to-batch color variation relates to precursor impurity profile or energy input stability, which is being addressed via supplier auditing and improved incoming QC analytics. Downstream, the main technical leap targets scalable column chromatography alternatives for high-throughput manufacturing while maintaining product purity for regulated markets.
Demand for 2-hydroxy-6-trifluoromethylpyridine hinges on the global trajectory of agrochemical innovation, ongoing pipeline expansion in small-molecule pharma, and the widening adoption of specialty fluorinated building blocks in functional material sectors. Order volumes remain closely tied to multi-year research collaborations with end-users and the introduction of new regulatory guidelines governing fluorinated intermediate manufacture and use.
Continuous process development is transitioning from batch to flow-based manufacturing lines. Automated in-process analytics are now standard for critical control points, letting the plant operate with tighter impurity control and reduced solvent usage. Raw material supply flexibility—especially for fluorinated reactants—drives much of the investment in feedstock management and diversion mitigation strategies.
Carbon footprint and sustainability metrics dominate internal decision-making on process selection and waste reduction. Efforts focus on closed-loop solvent recovery, fluorine recycling protocols, and energy optimization at reaction and distillation stages. As regulatory agencies further integrate green metrics, processes are moving toward benign CF3-sources and reducing reliance on halogenated solvents. R&D spending includes collaboration with academic labs to accelerate adoption of bio-based or less hazardous starting materials, where technically feasible.
Technical service teams provide application-focused advice grounded in production realities. Application chemists can advise on compatibility of 2-hydroxy-6-trifluoromethylpyridine grades with target synthetic transformations. Support addresses solvent selection, isolation yield, and impurity carryover questions using historical process data and customer-specific requirements.
Custom support for process scale-up includes recommendations on incoming QC protocols, impurity profile impact on downstream formulation, and safe handling practices during isolation. For clients transitioning between grades or shifting synthetic routes, production engineers help design robust in-process checks and impurity rejection strategies to maintain target purity levels and ensure traceability throughout production campaigns.
Customers receive full batch documentation per shipment, accompanied by technical review on any quality deviation or process bottleneck encountered in-use. Feedback channels direct recurrent technical issues to plant teams for root-cause analysis and preventive action implementation. On request, technical staff can support troubleshooting for filtration, dissolution, or any reprocessing needs directly at the customer’s site or through remote process review, with actions taken based on actual plant experience and QC data rather than generic troubleshooting scripts.
At our production site, every batch of 2-Hydroxy-6-trifluoromethylpyridine starts with hands-on control over every input—raw materials, reaction management, and downstream processing. Our process chemistry and plant design support steady output, and we apply clear process checks from synthesis right through to finished packaging. This isn’t a broker’s promise—it comes straight from our daily work on the plant floor.
The synthesis of 2-Hydroxy-6-trifluoromethylpyridine draws on direct experience with halogenated pyridines, where subtle adjustments in temperature, catalyst choice, and purification impact both assay and impurity profile. At no point do we hand control over to outsiders; our chemists and production engineers oversee each step, from chlorination to hydrolysis, with routine calibration and validated sampling. By holding that technical line, each industrial lot maintains its target chemical structure and purity, accommodating end-user expectations in scale-up as well as pilot runs.
Buyers in pharmaceuticals, agrochemicals, and materials synthesis demand assurance. This compound backs synthesis of APIs, crop protection intermediates, and polymer additives, where trace contaminants can jeopardize downstream reactions or force batch rework. We have longstanding supply commitments with process development teams who value traceable manufacturing records and reproducible results rather than a one-off sale.
Our plant operates under audited SOPs, including routine in-process checks and finished product release via chromatography and NMR. Batch records extend back five years, and control samples remain on hand for retrospective verification. Customers receive a verifiable lot history with each shipment, along with analysis reports that reflect true plant data—not generic specification sheets. This reduces the risk of regulatory flags in pharmaceutical or fine chemical compliance pipelines.
All 2-Hydroxy-6-trifluoromethylpyridine ships from our facility. We invest in packaging options purpose-built for moisture and UV-sensitive pyridine derivatives, such as lined HDPE drums, welded IBCs, and nitrogen blankets. Each package is weighed and sealed by trained plant staff, not at an external warehouse. Our shipping team manages regular FCL and LCL loads for global delivery, using forwarders with proven track records in hazardous shipments. Every consignment leaves with clear batch identification, relevant documentation, and transport compliance to minimize delays at ports and customs.
Our technical support doesn’t defer to third parties or consultants. Plant chemists and engineers address process questions, scale-up concerns, and impurity control measures directly. We welcome stability trials and side-by-side sample evaluations because this builds long-term confidence. Where a buyer's process needs tighter impurity control, or adjustments in solvates and crystal forms, our technical staff review lab data and coordinate with production leads to accommodate reliable, plant-scale delivery.
Our approach benefits manufacturers, distributors, and procurement specialists who need fewer surprises at the time of qualification, trial production, and regulatory dossier preparation. Each year, we audit and improve production controls, invest in analytical capabilities, and train staff to respond to changing market and customer needs. Manufacturers leveraging our direct supply chain reduce the cost and risk tied to substandard or variable input materials, supporting lean inventory strategies and fewer disruptive recalls.
Every lot reflects our experience with pyridine chemistry, direct plant management, and a business model focused on reliability, not short-term transaction volume. By maintaining custody and full records on every consignment, we provide a platform for buyers focused on robust, scalable chemical sourcing for demanding, regulated markets.
At our facility, we have manufactured and characterized 2-Hydroxy-6-trifluoromethylpyridine through multiple production cycles. We’ve worked closely with formulators, R&D chemists, and process engineers who rely on a close understanding of the material’s solubility for success in both pilot and industrial scale-up. Drawing from both our lab analytics and practical experience, we see a clear pattern in how this compound behaves across common organic solvents.
Our technical team observes that 2-Hydroxy-6-trifluoromethylpyridine dissolves readily in polar aprotic solvents. Acetonitrile, DMF, and DMSO support rapid dissolution without prolonged agitation or elevated temperature, often forming clear, stable solutions at concentrations relevant to most synthetic applications. Analytical feedback from our partners in both pharma and agrochemicals has reinforced these findings.
In less polar, but still oxygen-rich solvents like acetone and ethyl acetate, we see manageable solubility, especially when systems involve moderate heating or where concentration remains modest. Our internal tests typically show that preparative operations relying on these solvents can achieve homogeneous solutions after brief stirring.
Aliphatic hydrocarbons such as hexane do not provide suitable solubility for this molecule. We have consistently found that, even after extended mixing, only negligible dissolution occurs in straight-chain or branched hydrocarbons. For those considering solvent selection in scale-up or crystallization steps, we always recommend excluding hydrocarbon classes for anything beyond washing or phase separation. This is directly supported by gravimetric and visual solubility screening at our plant, not just data-sheet references.
Alcohols like methanol and ethanol grant reasonable solubility, though the rates are clearly solvent-dependent and improved with agitation and mild warming. Teams involved in extractions or work-up frequently turn to these alcohols for partial dissolution or sample preparation. For production runs where complete solubilization is mission-critical, we point toward DMSO or DMF instead; these solvents provide a level of assurance on both clarity and reproducibility.
The solubility behavior has a strong foundation in the molecule’s structure. The pyridine ring, its hydroxy substituent, and the trifluoromethyl group together generate polarity and hydrogen-bonding opportunities. That means solvents capable of accepting or donating hydrogen bonds will almost always outperform nonpolar options. Solvents with strong dipole moments or that act as both hydrogen bond donors and acceptors lead to rapid, even solubilization.
In practice, this translates to broad compatibility with standard polar solvents used in synthetic laboratories. Whether a team is developing new intermediates, tweaking process conditions, or scaling up crystallizations, our experience shows a direct connection between solvent polarity and operational efficiency. We advise our clients to match solvent selection not just to theoretical data, but to actual process requirements, always factoring in safety and downstream process impact.
Our quality team monitors every production batch for physical purity, moisture content, and uniformity, since solubility can shift with even trace-level contaminants. Technical data sheets are available, but real value emerges in tailored recommendations: our chemists have assisted partners in fine-tuning solvent blends, resolving filtration bottlenecks, and improving yields. We welcome process-specific questions directly, since conditions in a pilot reactor differ from a 10-liter flask—adjustments pay off.
We ship this product in lined drums or bottles designed to minimize moisture ingress, preserving its expected solubility profile through distribution. For those scaling up or troubleshooting, our technical team can provide laboratory and plant guidance informed by both structured testing and hands-on feedback across industries. Every shipment is backed by process transparency and access to direct assistance from manufacturing chemists familiar with its real-world behavior.
In chemical manufacturing, every operational decision connects directly to customer needs and factory realities. For products such as 2-Hydroxy-6-trifluoromethylpyridine, conversations regularly revolve around minimum order quantities (MOQ) and packaging formats. These factors shape project budgets, storage plans, and long-term supply agreements.
From our factory floor, MOQ takes on concrete significance. Each batch of 2-Hydroxy-6-trifluoromethylpyridine passes through synthesis, quality checks, filtering, and packing. Running a production line for a few kilos makes little sense, because set-up, raw material handling, and testing require the same level of precision as any full-scale job. Our MOQ reflects the entry point at which we deliver both product value and cost effectiveness. For this compound, most projects start at 1 kg as a minimum, balancing lab research requirements with the scale of industrial pilots. Orders at this level allow us to meet traceability standards and maintain consistency in batch integrity, which supports downstream formulation and validation.
Bulk chemicals like 2-Hydroxy-6-trifluoromethylpyridine need purpose-built packaging. Moisture, light, and contamination threaten product purity. Our team selects high-density polyethylene (HDPE) bottles, fluorinated containers, or lined steel drums, depending on the order size and handling logistics. The most common packaging sizes are 1 kg, 5 kg, and 25 kg containers. For kilo-scale research, 1 kg HDPE bottles ensure safe transport and practical lab use. Scale up to 5 kg and the packaging shifts, favoring chemical-resistant drums that protect large volumes during shipping.
Bigger process facilities often want 25 kg or more per shipment. In these cases, drums or high-integrity lined containers take over. We’ve invested in proper packing lines and factory QA to keep contamination risks low, with every lot certified before loading. Tailoring the packaging size isn’t just about shipment efficiency. In many cases, it can be about facilitating safer extraction and dosing into reactors, which affects both worker safety and batch yield.
Production schedules in specialty chemistry have little room for improvisation, yet flexibility wins long-term trust. Over the years, custom solutions for multinational clients have ranged from one-off small packs for validation runs, to multi-ton repeats for established synthesis processes. While standard sizes cover most applications, bespoke quantities and private-label packaging can streamline inventory management or meet regulatory import controls.
If a project demands alternative packaging—glass bottles for certain storage requirements or inert gas purging for extra-sensitive lots—our logistics and packaging engineering teams step in early. Investing in this flexibility has given us repeat business, especially among pharmaceutical processors and advanced materials manufacturers.
Trying to cut corners on order quantity or downgrade packaging never pays off. End-users might run into delays or incur quality failures downstream. That’s why our policy stays rooted in clear communication about MOQ, available packs, and the rationale behind those numbers. Transparency about these basic parameters always leads to smoother project starts and fewer surprises for our customers.
The approach is simple: candid technical dialogue, reliable specs, and real accountability as the manufacturer. The goal is always to support customers’ production needs with consistency and quality, from the very first kilogram through to multi-tonne supply.
From the manufacturing floor to loading dock, our regular routine centers on delivering high-purity materials with careful attention to safety and compliance. 2-Hydroxy-6-trifluoromethylpyridine, a specialty pyridine derivative, forms no exception in this regard. Most customers—whether working in pharmaceuticals, agrochemicals, or advanced materials—expect seamless international logistics and clear regulatory paperwork. Our logistics and technical safety teams coordinate these activities closely at every step.
Direct experience shows that 2-Hydroxy-6-trifluoromethylpyridine draws scrutiny during shipping due to possible chemical hazards linked to pyridine derivatives. Our safety assessments and regulatory checks indicate the current international regulations classify it differently depending on updates from authorities such as IATA, IMDG, and local customs offices. We review the GHS (Globally Harmonized System) classification, consulting our regularly updated safety data sheets before export.
We supply this compound in tightly sealed HDPE or fluorinated containers, sized for both bulk and lab quantities. These containers are tested to conform to pressure, leak, and compatibility standards to prevent loss of material and to keep hands, air, and water free from contamination. Every pallet receives sturdy secondary packaging and tamper-evident seals, engineered to perform through long customs holds or multimodal transport.
From our perspective as the product’s inventor and producer, proper documentation cuts shipping friction and helps safeguard all parties. Our shipments include a signed Certificate of Analysis with batch-specific purity and impurity details, a full Safety Data Sheet updated for the destination country’s requirements, and a Dangerous Goods declaration if the latest regulations identify it as such.
Customs in some regions require our specialized chemical product licenses or pollutant registration numbers. We handle these in advance as our compliance team routinely interfaces with hazardous chemical registries in the EU, US, Japan, and China. Where local language or additional country-specific requirements arise—a representative translation, extra hazard labeling, or supplemental legal declarations—we prepare the documents as part of our global shipping service.
Delays most often trace to gaps in paperwork or sudden changes in regulatory status at the destination port. Drawing from years of hands-on export experience, we maintain direct communication with major freight partners to adjust declarations and provide rapid-response corrections or clarifications where needed. Bottlenecks relating to restricted chemical lists or unexpected import licensing led us to standardize an export review protocol, confirming all necessary compliance points before dispatch.
Extreme temperatures, direct sunlight, and moisture threaten some sensitive organics. Our responsible care principles direct us to deploy insulated containers or temperature-controlled shipping when customer risk assessments call for it. Precise storage instructions and hazard labeling follow every shipment, not as formality, but as part of our commitment to downstream handlers in the logistic chain.
Global chemical control measures shift. Our regulatory affairs unit keeps the entire production team updated with monthly briefings. We revise packaging and paperwork promptly in line with global chemical safety harmonization, never leaving compliance to chance. This effort protects the customer and our own reputation for safe supply.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
